MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字H20223186

March 29, 2022

Drug Information

盐酸厄洛替尼片

片剂

150mg

化学药品

March 29, 2022

Company Information

Applicant Company

山东省曲阜市裕隆路37号

Manufacturing Company

曲阜市经济开发区(西区)工业一路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath